University of Missouri School of Medicine
Columbia, Missouri, 65212, United States
Location status: Recruiting
NCT Number: NCT05179954
The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.
Interested in participating?
Request Info18 year–45 year
All sexes
Interventional
Not applicable
Columbia, Missouri, 65212, United States
Location status: Recruiting
Not required
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Additional inclusion criteria for control subjects:
Additional inclusion criteria for subjects with T1DM:
Exclusion criteria
Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein C turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Triglyceride turnover rate will be assessed by using an intravenous stable isotope labeled glycerol infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein B-100 turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein C concentration
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Triglyceride concentration
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein B-100 concentration
Contact information is provided by the study sponsor or research team.
University of Missouri-Columbia
Other
Apolipoprotein C3-loading of Apolipoprotein B100 Lipoproteins and Cardiovascular Disease in Patients With Type 1 Diabetes
Acronym: LTD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07413874
Addison Disease, Adrenal Gland Diseases
Boone, North Carolina, United States
View Trial DetailsNCT06524960
Autoimmune Diseases, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT06654713
Autoimmune Diseases, Diabetes Mellitus
San Francisco, California, United States
View Trial DetailsNCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial Details